Elevara Medicines

Developer of a targeted therapy addressing rheumatoid arthritis through fibroblast modulation

placeLondon, England, United Kingdom calendar_todayFounded 2025 language elevara.com

Social engagement

Social engagement: 1K social following, 3 posts in the last 12 months — top 10% of its industry.

Investor mix

4 investors on record; lead investors include Forbion, Sofinnova Partners.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%

Recent activity

16 Mar 2026
Milestone
regulatory
Coming soon